Core Viewpoint - The company, Langkun Technology, is addressing investor concerns regarding project completion timelines, current sales of biodiesel, and its long-term vision to become a world-class bio-manufacturing enterprise [1] Group 1: Project and Sales Information - The company has been asked about the completion timeline for the Fangshan and Tongzhou projects, which are expected to be completed by 2026 [1] - Current sales figures for biodiesel were not disclosed, with the company indicating that specific details will be provided in future reports or announcements [1] Group 2: Long-term Vision and Strategic Response - Langkun Technology aims to focus on core technology research in bio-manufacturing, expand into high-value product areas, optimize production capacity and supply chain, and enhance talent development to improve market competitiveness [1] - In response to the Shenzhen government's plan for a 7 trillion yuan increase in market capitalization for listed companies by 2027, the company plans to actively engage in its main business, improve operational performance, and enhance communication with investors to align its value and market capitalization [1]

Core Viewpoint - Longkun Technology (301305) is actively addressing investor concerns regarding project completion timelines, sales of biodiesel, and its strategic vision to become a world-class bio-manufacturing enterprise, while also responding to local government initiatives for market capitalization growth by 2027 [1] Group 1: Project and Sales Information - The company has been asked about the completion timeline for the Fangshan and Tongzhou projects, which are expected to be completed by 2026 [1] - Current sales figures for biodiesel were not disclosed, with the company indicating that specific details will be provided in future reports [1] Group 2: Strategic Vision and Government Response - Longkun Technology aims to focus on core technology research in bio-manufacturing, expand into high-value product areas, optimize production capacity and supply chain, and enhance talent development to improve market competitiveness [1] - In response to the Shenzhen government’s plan for a 7 trillion yuan increase in market capitalization for listed companies by 2027, the company plans to deepen its core business, improve operational performance, and enhance investor communication to align its value and market capitalization [1]

Investment Rating - The report maintains a positive outlook on the power and gas sectors, recommending various companies within these industries based on their performance and market conditions [2]. Core Insights - The report highlights a significant increase in electricity consumption in October, with a year-on-year growth of 10.4%, driven primarily by the tertiary sector and residential usage [5][10]. - Natural gas prices exhibit mixed trends globally, with U.S. prices rising while European prices are stabilizing [22][30]. - The report provides specific investment recommendations across various segments, including hydropower, green energy, nuclear power, thermal power, and gas [20][21]. Summary by Sections 1. Electricity Sector - In October, total electricity consumption reached 857.2 billion kWh, marking a 10.4% increase year-on-year. The first, second, and third industries, along with residential consumption, saw growth rates of 13.2%, 6.2%, 17.1%, and 23.9%, respectively [12][10]. - The tertiary sector's electricity consumption grew the fastest, particularly in internet data services related to big data and AI, which surged by 46% [11]. - The report notes that the second industry contributes over 60% of total electricity consumption, with high-tech and equipment manufacturing showing significant growth [11][12]. 2. Gas Sector - As of November 21, U.S. Henry Hub spot prices were $4.13/mmBtu, reflecting an 18.33% weekly increase, while European gas prices showed slight declines [22][30]. - The report indicates that U.S. natural gas supply remains robust, with a notable increase in LNG demand, contributing to rising prices [24][25]. - Recommendations include focusing on integrated gas companies and those benefiting from cost reductions and increased sales, such as Kunlun Energy and New Hope Energy [44]. 3. Weekly Market Review - The report notes that the public utility, gas, and power equipment sectors underperformed compared to the Shanghai and Shenzhen 300 index during the week of November 17 to November 21 [47]. 4. Company and Industry Dynamics - The report discusses the commissioning of China's highest-altitude wind power project in Tibet, which is expected to provide significant clean energy and economic benefits to the local community [50][53]. - It also highlights various local government initiatives aimed at promoting green electricity and renewable energy projects, including direct connections for green electricity [54][55].

Group 1 - The core point of the article is that Zhuhai Langjian Biotech's production line is currently in trial production, with the first phase of the 260-ton project progressing in an orderly manner [2] - The company, Longkun Technology (301305.SZ), confirmed the status of the production line in response to investor inquiries on an interactive platform [2] - Further updates on business progress will be disclosed through official announcements or subsequent periodic reports [2]

Investment Rating - The report maintains a "Positive" outlook on the public utilities and environmental protection sectors [3] Core Insights - The report highlights a significant increase in electricity production in October, with total generation reaching 800.2 billion kWh, a year-on-year growth of 7.9% [4][11] - Hydropower and thermal power contributed the most to the increase in electricity generation, while wind power saw a decline of 11.9% compared to the previous year [4][10] - Natural gas prices showed mixed trends globally, with stable prices in Asia and fluctuations in Europe and North America [22][40] Summary by Sections 1. Electricity Production - In October, thermal power generation was 513.8 billion kWh, up 7.3% year-on-year, while hydropower generation reached 135.1 billion kWh, up 28.2% [4][11] - The total increase in electricity generation for October was approximately 58.6 billion kWh, with thermal power contributing 35 billion kWh and hydropower contributing 29.7 billion kWh [10][11] - The Three Gorges Reservoir achieved its water storage target of 175 meters, supporting future hydropower generation [10] 2. Natural Gas Market - As of November 14, the Henry Hub spot price in the U.S. was $3.49/mmBtu, a weekly decrease of 7.32% [22] - The TTF spot price in Europe was €30.80/MWh, showing a slight weekly change of 0.81% [22] - Northeast Asia's LNG spot price remained stable at $11.10/mmBtu, with domestic supply being sufficient [22][40] 3. Investment Recommendations - For hydropower, the report recommends companies like Guotou Power, Chuan Investment Energy, and Huaneng Hydropower due to favorable autumn water conditions [20] - In the green energy sector, companies such as Xintian Green Energy and Longyuan Power are suggested for their stable returns and high utilization hours [20] - For nuclear power, the report highlights China Nuclear Power and China General Nuclear Power as key players due to ongoing approvals for new units [20] - In the thermal power sector, companies like Guodian Power and Inner Mongolia Huadian are recommended due to decreasing fuel costs [20] - The report also suggests focusing on integrated natural gas companies like Kunlun Energy and New Hope Energy for their potential recovery in profitability [42][43]

Investment Rating - The report maintains an investment rating of "Outperform the Market - A" [5] Core Insights - The application of Human Milk Oligosaccharides (HMOs) is expected to accelerate, driven by their recognized nutritional benefits and expanding regulatory approvals [3] - The infant formula market is experiencing increased concentration, with the top 10 companies' market share rising from 68% in 2017 to 83% in Q3 2025, indicating a shift towards premium product offerings that include HMOs [2] - The potential market space for HMOs in the Chinese infant formula sector is estimated to be between 5.86 billion to 11.72 billion yuan, based on projected production and pricing [2] Summary by Sections HMO Nutritional Benefits - HMOs are the third largest nutritional component in breast milk, consisting of various structures that contribute positively to infant health, including growth, gut health, immunity, and cognitive development [1] Market Dynamics - The implementation of stringent new standards for infant formula has led to significant market consolidation and a focus on nutritional enhancement, with major brands introducing HMO-enriched products [2] - The expected production of infant formula in China for 2024 is approximately 1.563 million tons, with a significant portion anticipated to be high-end products requiring HMO addition [2] Regulatory Developments - Recent approvals by health authorities to expand the use of HMOs in various food products indicate a growing recognition of their value, which could lead to exponential market growth if HMOs are utilized beyond infant formula [3] - Companies like Ganbaiyou and Qiu Tian Man Man are already responding to these regulatory changes by launching HMO-added products [3] Company Focus - Companies such as Langkun Technology, Baolingbao, and Jiabiyou are actively developing HMO production capabilities, with significant annual production capacities planned [10]

证券代码：301305 证券简称：朗坤科技 公告编号：2025-078 深圳市朗坤科技股份有限公司 关于为子公司提供担保事项的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市朗坤科技股份有限公司（以下简称"公司"）分别于 2025 年 4 月 23 日、2025 年 5 月 16 日召开第三届董事会第二十二次会议、第三届监事会第十三 次会议以及 2024 年年度股东大会，审议通过了《关于公司 2025 年度对外担保额 度预计的议案》。为满足公司及合并报表范围内子公司业务发展融资需求（包括 但不限于办理人民币流动资金贷款、项目贷款、贸易融资、银行承兑汇票、保函、 信用证等形式），同意公司及子公司在保证规范运营和风险可控的前提下，2025 年度新增不超过人民币 159,244.50 万元的担保额度。其中，为资产负债率高于 70%的子公司提供担保额度合计不超过人民币 2,638.70 万元，为资产负债率低于 70%的子公司提供担保额度合计不超过人民币 156,605.80 万元。公司可以根据实 际情况，在上述担保额度范围内，以不超过资产负债率 70% ...

Core Viewpoint - The company, Langkun Technology (301305.SZ), has stated that it is currently not utilizing synthetic biology technology to produce D-Allulose sugar [1] Group 1 - The company is actively engaging with investors through an interactive platform [1] - There is a focus on synthetic biology technology within the industry, particularly regarding its applications in sugar production [1]

Core Viewpoint - The company has not utilized synthetic biology technology for the production of D-allulose sugar [1] Group 1 - The company is currently not engaged in the production of D-allulose sugar using synthetic biology technology [1]

Core Insights - The company focuses on two core businesses: biomass resource regeneration and synthetic biological manufacturing [1] - The domestic competitors are distributed across corresponding niche fields, indicating a competitive landscape [1] - The company possesses differentiated competitive advantages in both fields and plans to strengthen technological innovation and project implementation to consolidate its position in niche markets [1]